The first stop for professional medicines advice

Mirabegron

Published
Topics: CCG commissioned new medicinesMirabegronNew Medicines · Patent expiriesRenal and urologic disordersSafety in BreastfeedingStability in dosette boxes ·
Contents
  1. dm+d
  2. Articles
  3. Medicine Compliance Aid Stability
    1. Betmiga · Astellas Pharma Ltd
  4. Lactation Safety Information

dm+d

703804000

Articles

Treating urinary disorders during breastfeeding

21 March 2023Oxybutynin is preferred for urinary frequency, enuresis, and incontinence during breastfeeding. Recommendations apply to full term and healthy infants only.
Search Articles

Medicine Compliance Aid Stability

BetmigaAstellas Pharma Ltd

Astellas Pharma Ltd
Betmiga
Tablets m/r 25mg, 50mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special precautions for storage.
29 September 2022
Usage of Medicines in Compliance Aids

Lactation Safety Information

Caution
Oxybutynin
Long half-life increases risk of accumulation in breastfed infants
No published evidence of safety
Safety in Lactation: Drugs for urinary frequency, enuresis, and incontinence
22 September 2020